Physician profile
Albin John Abraham
NPI 1790917870
$1,144.26
in general payments reported to CMS, 2019-2025
17 companies · $533 in 2025
The $533 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.73 · 2020: $169 · 2021: $121 · 2022: $131 · 2023: $59.80 · 2024: $57.94 · 2025: $533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $650.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $252.92 | 2025 | Interstim, Pillcam |
| Celgene Corporation | $190.79 | 2022-2023 | Zeposia |
| Abbvie INC. | $151.29 | 2020-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $74.49 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $73.18 | 2025 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $71.39 | 2019-2021 | |
| Madrigal Pharmaceuticals | $67.18 | 2025 | Rezdiffra |
| Biocomposites INC | $57.94 | 2024 | |
| Pfizer INC. | $49.56 | 2025 | |
| Nestle Healthcare Nutrition INC. | $40.33 | 2021 | |
| Ardelyx, INC. | $27.07 | 2025 | Ibsrela |
| Janssen Biotech, INC. | $21.94 | 2025 | Simponi, Simponi Aria, Stelara |
| Vifor Pharma, INC. | $18.40 | 2019 | |
| Redhill Biopharma INC. | $12.89 | 2020 | |
| Allergan, INC. | $11.89 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alfasigma USA, INC. | $11.72 | 2020 | |
| Braintree Laboratories, INC. | $11.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albin Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.